ArticleFrontiers in oncology2022

OGG1 Inhibition Triggers Synthetic Lethality and Enhances The Effect of PARP Inhibitor Olaparib in BRCA1-Deficient TNBC Cells.

Juan Miguel Baquero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.